The Center serves as a referral resource for diagnosis and treatment of primary immune deficiency (PID) diseases. Physician and school nurse education and public awareness campaigns are conducted by the Center to achieve the goal of reaching the estimated 50% of patients with primary immune deficiency diseases who currently go undiagnosed.
The Center also serves as a source of expertise in the new FDA-approved subcutaneous delivery system for immunoglobulins. That procedure was initially developed by Dr. Berger, and Rainbow served as one of the sites for the clinical trials which led to FDA approval of this therapy. Patients and physicians can learn more about this alternative to intravenous immunoglobulins (IGIV) treatment by contacting the Center at 216-844-3237.
The Center can also put patients with PID diseases in contact with the patient support groups and additional sources of information. Both adults and children are seen by Center physicians at Landerbrook, Westlake and Strongsville offices. IGIV infusions are also given at those sites.
Patients seeking appointments should call (216) 844-7700.